Davies Davies MA MA Saiag Saiag P P Robert Robert C C Grob Grob JJ JJ Flaherty Flaherty KT KT Arance Arance A A Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial Lancet Oncol Lancet Oncol 2017 2017 18 18 7 7 863 863 873 873 10.1016/S1470-2045(17)30429-1 10.1016/S1470-2045(17)30429-1 28592387 28592387. This evidence concerns the gene BRAF and melanoma.